African American men suffer from prostate cancer more often than white men, yet new research shows that they respond as well — or even better — to advanced treatment methods.
Archive for tag: dr david samadi
Caffeine addicts might have some good news thanks to a new research study detailing how certain chemical compounds in coffee can help protect against certain types of drug-resistant prostate cancer.
The results of a new research study have revealed that prostate cancer is becoming less deadly, and has been in decline in both diagnoses and deaths.
New analytical research into electronic health record data classification methods may hold the key for helping model prostate cancer survival rate predictions in the future.
A new nerve grafting technique has successfully been used to combat erectile dysfunction in men who have undergone prostate removal surgery in the past, a new research paper claims.
Early results are in from a clinical trial for new prostate cancer treatment drug darolutamide, showcasing the promise of better treatment for specific types of prostate tumors.
Early results in the Phase 2 GALAHAD clinical trial for the anti-cancer drug Zejula show promise in treating patients suffering from specific types of prostate cancer.
A newly-published research study out of Denmark has found that low-dose aspirin, while beneficial for some men’s health issues, does little to help patients diagnosed with prostate cancer.
Researchers have discovered that few patients are using androgen deprivation therapy (ADT) to its fullest advantage despite how effective it is in treating many types of prostate cancer.